ICCC Insider Trading
Insider Ownership Percentage: 5.60%
Insider Buying (Last 12 Months): $7,773.08
Insider Selling (Last 12 Months): $0.00
ImmuCell Share Price & Price History
Current Price: $5.21
Price Change: ▼ Price Decrease of -0.04 (-0.76%)
As of 12/4/2025 05:00 PM ET
ImmuCell Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 11/25/2025 | David Scott Tomsche | Director | Buy | 1,633 | $4.76 | $7,773.08 | 52,720 |  |
ImmuCell Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 12/2/2025 | Steadtrust LLC | 31,700 | $0.20M | 0.1% | N/A | 0.350% |  |
| 11/17/2025 | Citadel Advisors LLC | 21,469 | $0.14M | 0.0% | -47.6% | 0.237% | |
| 11/14/2025 | Dauntless Investment Group LLC | 87,121 | $0.55M | 0.3% | -8.0% | 0.963% | |
| 11/12/2025 | Dimensional Fund Advisors LP | 62,305 | $0.40M | 0.0% | -10.9% | 0.689% | |
| 8/8/2025 | Geode Capital Management LLC | 71,852 | $0.50M | 0.0% | +4.2% | 0.795% | |
| 5/8/2025 | Mesirow Financial Investment Management Inc. | 12,178 | $58K | 0.0% | -50.0% | 0.135% | |
| 2/17/2025 | Cresset Asset Management LLC | 132,001 | $0.68M | 0.0% | -50.0% | 1.481% | |
| 2/17/2025 | Citadel Advisors LLC | 29,021 | $0.15M | 0.0% | N/A | 0.326% | |
| 2/14/2025 | Northern Trust Corp | 44,374 | $0.23M | 0.0% | +51.0% | 0.498% | |
| 2/14/2025 | Dauntless Investment Group LLC | 131,195 | $0.68M | 0.7% | N/A | 1.472% | |
| 2/14/2025 | Dimensional Fund Advisors LP | 66,306 | $0.34M | 0.0% | -8.8% | 0.744% | |
| 2/13/2025 | Renaissance Technologies LLC | 136,989 | $0.71M | 0.0% | -8.4% | 1.537% | |
| 2/12/2025 | Geode Capital Management LLC | 64,538 | $0.33M | 0.0% | +13.9% | 0.724% | |
| 2/7/2025 | Mesirow Financial Investment Management Inc. | 24,356 | $0.13M | 0.0% | +100.0% | 0.273% | |
| 4/26/2024 | Mesirow Financial Investment Management Inc. | 12,178 | $65K | 0.0% | N/A | 0.157% | |
| 11/16/2023 | Essex Financial Services Inc. | 11,000 | $59K | 0.0% | -21.4% | 0.142% | |
| 11/6/2023 | HM Payson & Co. | 6,000 | $31K | 0.0% | -50.5% | 0.077% | |
| 10/24/2023 | Mission Wealth Management LP | 10,000 | $53K | 0.0% | N/A | 0.129% | |
| 8/14/2023 | Perritt Capital Management Inc. | 27,026 | $0.14M | 0.1% | -8.9% | 0.349% | |
| 7/17/2023 | HM Payson & Co. | 12,130 | $62K | 0.0% | +49.2% | 0.157% | |
| 5/15/2023 | Overbrook Management Corp | 32,857 | $0.17M | 0.0% | -7.5% | 0.424% | |
| 4/20/2023 | Empire Financial Management Company LLC | 42,000 | $0.22M | 0.1% | N/A | 0.542% | |
| 4/13/2023 | Prosperity Planning Inc. | 16,000 | $82K | 0.0% | N/A | 0.206% | |
| 1/13/2023 | Flagship Harbor Advisors LLC | 14,230 | $87K | 0.0% | -12.3% | 0.184% | |
| 10/24/2022 | Shufro Rose & Co. LLC | 62,408 | $0.47M | 0.0% | -23.9% | 0.806% | |
| 8/11/2022 | Overbrook Management Corp | 35,532 | $0.31M | 0.1% | -22.5% | 0.459% | |
| 5/11/2022 | Bleichroeder LP | 71,073 | $0.69M | 0.1% | +14.2% | 0.918% | |
| 5/9/2022 | Shufro Rose & Co. LLC | 82,046 | $0.79M | 0.1% | +358.1% | 1.060% | |
| 2/15/2022 | HM Payson & Co. | 8,130 | $65K | 0.0% | +306.5% | 0.105% | |
| 2/14/2022 | Overbrook Management Corp | 75,469 | $0.60M | 0.1% | -8.1% | 0.975% | |
| 2/10/2022 | Bleichroeder LP | 62,249 | $0.50M | 0.1% | +2.7% | 0.804% | |
| 2/9/2022 | Wealth Effects LLC | 15,850 | $0.13M | 0.1% | N/A | 0.205% | |
| 1/18/2022 | Aries Wealth Management | 44,100 | $0.35M | 0.0% | N/A | 0.570% | |
| 11/15/2021 | HighTower Advisors LLC | 18,254 | $0.17M | 0.0% | +15.9% | 0.236% | |
| 11/12/2021 | Renaissance Technologies LLC | 176,322 | $1.65M | 0.0% | -1.0% | 2.277% | |
| 11/10/2021 | Essex Financial Services Inc. | 14,000 | $0.13M | 0.0% | N/A | 0.181% | |
| 11/9/2021 | BlackRock Inc. | 14,793 | $0.14M | 0.0% | +21.3% | 0.191% | |
| 10/12/2021 | Koshinski Asset Management Inc. | 2,900 | $27K | 0.0% | N/A | 0.037% | |
Data available starting January 2016
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, it is developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.
Read More on ImmuCell
Volume
47,233 shs
Average Volume
18,223 shs
Market Capitalization
$47.15 million
P/E Ratio
20.04
Dividend Yield
N/A
Beta
0.2
Who are the company insiders with the largest holdings of ImmuCell?
Who are the major institutional investors of ImmuCell?
Which institutional investors are selling ImmuCell stock?
Within the last quarter, ICCC stock was sold by these institutional investors:
- Citadel Advisors LLC
- Dimensional Fund Advisors LP
- Dauntless Investment Group LLC
Which institutional investors are buying ImmuCell stock?
In the previous quarter, ICCC stock was bought by institutional investors including:
- Steadtrust LLC
